Brewin Dolphin Wealth Management LTD Vertex Pharmaceuticals Inc Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 602 shares of VRTX stock, worth $239,156. This represents 0.02% of its overall portfolio holdings.
Number of Shares
602
Previous 301
100.0%
Holding current value
$239,156
Previous $79,000
107.59%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.7 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.2 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.47 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.69 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.58 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $102B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...